
Company Number
03527451
Next Accounts
Feb 2026
Directors
Shareholders
diomed developments limited
Group Structure
View All
Industry
Non-trading company
Registered Address
haslers, old station road, loughton, essex, IG10 4PL
Website
www.diomed.co.ukPomanda estimates the enterprise value of DIOMED PHARMACEUTICALS LIMITED at £0 based on a Turnover of £0 and 0.5x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of DIOMED PHARMACEUTICALS LIMITED at £0 based on an EBITDA of £0 and a 4.74x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of DIOMED PHARMACEUTICALS LIMITED at £113 based on Net Assets of £100 and 1.13x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Diomed Pharmaceuticals Limited is a live company located in loughton, IG10 4PL with a Companies House number of 03527451. It operates in the non-trading company sector, SIC Code 74990. Founded in March 1998, it's largest shareholder is diomed developments limited with a 100% stake. Diomed Pharmaceuticals Limited is a mature, unknown sized company, Pomanda has estimated its turnover at £0 with unknown growth in recent years.
There is insufficient data available to calculate a health check for Diomed Pharmaceuticals Limited. Company Health Check FAQs
0 Strong
0 Regular
0 Weak
Size
There is insufficient data available for this Key Performance Indicator!
- - Diomed Pharmaceuticals Limited
- - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- Diomed Pharmaceuticals Limited
- - Industry AVG
Production
There is insufficient data available for this Key Performance Indicator!
- Diomed Pharmaceuticals Limited
- - Industry AVG
Profitability
There is insufficient data available for this Key Performance Indicator!
- Diomed Pharmaceuticals Limited
- - Industry AVG
Employees
There is insufficient data available for this Key Performance Indicator!
- - Diomed Pharmaceuticals Limited
- - Industry AVG
Pay Structure
There is insufficient data available for this Key Performance Indicator!
- Diomed Pharmaceuticals Limited
- - Industry AVG
Efficiency
There is insufficient data available for this Key Performance Indicator!
- Diomed Pharmaceuticals Limited
- - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- Diomed Pharmaceuticals Limited
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- Diomed Pharmaceuticals Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Diomed Pharmaceuticals Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Diomed Pharmaceuticals Limited
- - Industry AVG
Debt Level
There is insufficient data available for this Key Performance Indicator!
- - Diomed Pharmaceuticals Limited
- - Industry AVG
Diomed Pharmaceuticals Limited's latest turnover from May 2024 is estimated at 0 and the company has net assets of £100. According to their latest financial statements, we estimate that Diomed Pharmaceuticals Limited has no employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
May 2024 | May 2023 | May 2022 | May 2021 | May 2020 | May 2019 | May 2018 | May 2017 | May 2016 | May 2015 | May 2014 | May 2013 | May 2012 | May 2011 | May 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | |||||||||||||||
Other Income Or Grants | |||||||||||||||
Cost Of Sales | |||||||||||||||
Gross Profit | |||||||||||||||
Admin Expenses | |||||||||||||||
Operating Profit | |||||||||||||||
Interest Payable | |||||||||||||||
Interest Receivable | |||||||||||||||
Pre-Tax Profit | |||||||||||||||
Tax | |||||||||||||||
Profit After Tax | |||||||||||||||
Dividends Paid | |||||||||||||||
Retained Profit | |||||||||||||||
Employee Costs | |||||||||||||||
Number Of Employees | |||||||||||||||
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
May 2024 | May 2023 | May 2022 | May 2021 | May 2020 | May 2019 | May 2018 | May 2017 | May 2016 | May 2015 | May 2014 | May 2013 | May 2012 | May 2011 | May 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | |||||||||||||||
Intangible Assets | |||||||||||||||
Investments & Other | |||||||||||||||
Debtors (Due After 1 year) | |||||||||||||||
Total Fixed Assets | |||||||||||||||
Stock & work in progress | |||||||||||||||
Trade Debtors | |||||||||||||||
Group Debtors | 100 | 100 | 100 | 100 | 100 | 100 | |||||||||
Misc Debtors | |||||||||||||||
Cash | |||||||||||||||
misc current assets | |||||||||||||||
total current assets | 100 | 100 | 100 | 100 | 100 | 100 | |||||||||
total assets | 100 | 100 | 100 | 100 | 100 | 100 | |||||||||
Bank overdraft | |||||||||||||||
Bank loan | |||||||||||||||
Trade Creditors | |||||||||||||||
Group/Directors Accounts | |||||||||||||||
other short term finances | |||||||||||||||
hp & lease commitments | |||||||||||||||
other current liabilities | |||||||||||||||
total current liabilities | |||||||||||||||
loans | |||||||||||||||
hp & lease commitments | |||||||||||||||
Accruals and Deferred Income | |||||||||||||||
other liabilities | |||||||||||||||
provisions | |||||||||||||||
total long term liabilities | |||||||||||||||
total liabilities | |||||||||||||||
net assets | 100 | 100 | 100 | 100 | 100 | 100 | |||||||||
total shareholders funds | 100 | 100 | 100 | 100 | 100 | 100 |
May 2024 | May 2023 | May 2022 | May 2021 | May 2020 | May 2019 | May 2018 | May 2017 | May 2016 | May 2015 | May 2014 | May 2013 | May 2012 | May 2011 | May 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | |||||||||||||||
Operating Profit | |||||||||||||||
Depreciation | |||||||||||||||
Amortisation | |||||||||||||||
Tax | |||||||||||||||
Stock | |||||||||||||||
Debtors | 100 | ||||||||||||||
Creditors | |||||||||||||||
Accruals and Deferred Income | |||||||||||||||
Deferred Taxes & Provisions | |||||||||||||||
Cash flow from operations | |||||||||||||||
Investing Activities | |||||||||||||||
capital expenditure | |||||||||||||||
Change in Investments | |||||||||||||||
cash flow from investments | |||||||||||||||
Financing Activities | |||||||||||||||
Bank loans | |||||||||||||||
Group/Directors Accounts | |||||||||||||||
Other Short Term Loans | |||||||||||||||
Long term loans | |||||||||||||||
Hire Purchase and Lease Commitments | |||||||||||||||
other long term liabilities | |||||||||||||||
share issue | |||||||||||||||
interest | |||||||||||||||
cash flow from financing | |||||||||||||||
cash and cash equivalents | |||||||||||||||
cash | |||||||||||||||
overdraft | |||||||||||||||
change in cash |
Perform a competitor analysis for diomed pharmaceuticals limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other mature companies, companies in IG10 area or any other competitors across 12 key performance metrics.
DIOMED PHARMACEUTICALS LIMITED group structure
Diomed Pharmaceuticals Limited has no subsidiary companies.
Ultimate parent company
2 parents
DIOMED PHARMACEUTICALS LIMITED
03527451
Diomed Pharmaceuticals Limited currently has 1 director, Mr Michael Yarrow serving since Mar 1998.
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Michael Yarrow | United Kingdom | 77 years | Mar 1998 | - | Director |
P&L
May 2024turnover
0
0%
operating profit
0
0%
gross margin
0%
0%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
May 2024net assets
100
0%
total assets
100
0%
cash
0
0%
net assets
Total assets minus all liabilities
Similar Companies
company number
03527451
Type
Private limited with Share Capital
industry
74990 - Non-trading company
incorporation date
March 1998
age
27
incorporated
UK
ultimate parent company
accounts
Dormant
last accounts submitted
May 2024
previous names
N/A
accountant
-
auditor
-
address
haslers, old station road, loughton, essex, IG10 4PL
Bank
-
Legal Advisor
-
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to diomed pharmaceuticals limited.
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for DIOMED PHARMACEUTICALS LIMITED. This can take several minutes, an email will notify you when this has completed.
date | description | view/download |
---|